{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:10:58Z","timestamp":1789035058355,"version":"build-2803163510"},"reference-count":80,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lineage plasticity is a major mechanism by which prostate cancer adapts to therapeutic pressure, particularly following sustained inhibition of androgen receptor signaling. A central mediator of this process is BRN2, a POU3F2 neural lineage transcription factor that is normally suppressed in AR-dependent luminal prostate epithelium but becomes aberrantly activated during progression to castration-resistant and neuroendocrine (NE) prostate cancer. This review examines how BRN2 connects developmental neurogenesis to therapy-induced tumor reprogramming. We integrate insights from neurodevelopment and direct lineage reprogramming to describe how BRN2 maintains stem-like and NE transcriptional states. Mechanistically, we discuss how AR suppression, cooperating oncogenic drivers, epigenetic remodeling, and post-translational modification activate BRN2 and reshape transcriptional networks involving SOX2, Wnt signaling, N-Myc, and EZH2. We also evaluate strategies to target BRN2 and its associated dependencies, including direct inhibition of BRN2 DNA binding and pharmacologic disruption of cooperating epigenetic complexes such as BRD4, EZH2, and LSD1, though EZH2 inhibition may paradoxically promote further NE differentiation. We additionally assess BRN2 as a potential circulating biomarker, detectable in extracellular vesicles, though no clinical-grade assay has been validated. This review highlights BRN2 as a key transcriptional regulator of lineage plasticity in prostate cancer, with important implications for overcoming therapy resistance in advanced prostate cancer.<\/jats:p>","DOI":"10.1210\/endocr\/bqag102","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:50:56Z","timestamp":1788407456000},"source":"Crossref","is-referenced-by-count":0,"title":["BRN2 in lineage plasticity: a prostate cancer-focused perspective"],"prefix":"10.1210","volume":"167","author":[{"given":"Fatemeh","family":"Seilani","sequence":"first","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Esfini Farahani","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos Olalekan","family":"Akinyemi","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-1746","authenticated-orcid":false,"given":"Xiaoqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Cancer Biology, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]},{"name":"Markey Cancer Center, University of Kentucky , Lexington, KY 40536 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"1","key":"2026091005362459500_bqag102-B1","doi-asserted-by":"crossref","first-page":"14284","DOI":"10.1038\/ncomms14284","article-title":"Dissecting cell-type-specific roles of androgen receptor in prostate homeostasis and regeneration through lineage tracing","volume":"8","author":"Xie","year":"2017","journal-title":"Nat Commun"},{"issue":"11","key":"2026091005362459500_bqag102-B2","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Beltran","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"24","key":"2026091005362459500_bqag102-B3","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"issue":"23","key":"2026091005362459500_bqag102-B4","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026091005362459500_bqag102-B5","first-page":"0005","article-title":"Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance","volume":"1","author":"Jamroze","year":"2024","journal-title":"Cancer Heterog Plast"},{"issue":"4","key":"2026091005362459500_bqag102-B6","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI131041","article-title":"Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer","volume":"130","author":"Beltran","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"2026091005362459500_bqag102-B7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"issue":"6","key":"2026091005362459500_bqag102-B8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"6320","key":"2026091005362459500_bqag102-B9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"issue":"6320","key":"2026091005362459500_bqag102-B10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"30","key":"2026091005362459500_bqag102-B11","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2013.54.3553","article-title":"Neuroendocrine prostate cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis\u2014a systematic review and pooled analysis","volume":"32","author":"Wang","year":"2014","journal-title":"J Clin Oncol"},{"issue":"8","key":"2026091005362459500_bqag102-B12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41388-022-02498-1","article-title":"TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer","volume":"42","author":"Fan","year":"2023","journal-title":"Oncogene"},{"issue":"10","key":"2026091005362459500_bqag102-B13","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1093\/nar\/gkae206","article-title":"SIX2 promotes cell plasticity via Wnt\/\u03b2-catenin signalling in androgen receptor independent prostate cancer","volume":"52","author":"Lepp\u00e4nen","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2026091005362459500_bqag102-B14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-15-1263","article-title":"The master neural transcription factor BRN2 is an androgen receptor\u2013suppressed driver of neuroendocrine differentiation in prostate cancer","volume":"7","author":"Bishop","year":"2017","journal-title":"Cancer Discov"},{"issue":"2","key":"2026091005362459500_bqag102-B15","doi-asserted-by":"crossref","first-page":"101556","DOI":"10.1016\/j.jbc.2021.101556","article-title":"Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity","volume":"298","author":"Monga","year":"2022","journal-title":"J Biol Chem"},{"issue":"20","key":"2026091005362459500_bqag102-B16","doi-asserted-by":"crossref","first-page":"e2404938","DOI":"10.1002\/advs.202404938","article-title":"Deciphering the transcription factor landscape in prostate cancer progression: a novel approach to understand NE transdifferentiation","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"23","key":"2026091005362459500_bqag102-B17","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3390\/cells13231999","article-title":"Therapeutic exploitation of neuroendocrine transdifferentiation drivers in prostate cancer","volume":"13","author":"Maylin","year":"2024","journal-title":"Cells"},{"issue":"3","key":"2026091005362459500_bqag102-B18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/bco2.212","article-title":"Genomic alterations in neuroendocrine prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Chen","year":"2023","journal-title":"BJUI Compass"},{"issue":"7","key":"2026091005362459500_bqag102-B19","doi-asserted-by":"crossref","first-page":"104576","DOI":"10.1016\/j.isci.2022.104576","article-title":"Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer","volume":"25","author":"Wang","year":"2022","journal-title":"IScience"},{"issue":"46","key":"2026091005362459500_bqag102-B20","doi-asserted-by":"crossref","first-page":"e2513468122","DOI":"10.1073\/pnas.2513468122","article-title":"Circadian regulator REV-ERB\u03b1 is a master regulator of tumor lineage plasticity and an effective therapeutic target","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2026091005362459500_bqag102-B21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.apsb.2025.01.007","article-title":"Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"2026091005362459500_bqag102-B22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1755-148X.2008.00510.x","article-title":"POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis","volume":"21","author":"Cook","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"issue":"11","key":"2026091005362459500_bqag102-B23","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/cercor\/bhs252","article-title":"POU-III transcription factors (Brn1, Brn2, and Oct6) influence neurogenesis, molecular identity, and migratory destination of upper-layer cells of the cerebral cortex","volume":"23","author":"Dominguez","year":"2013","journal-title":"Cerebral Cortex"},{"issue":"21","key":"2026091005362459500_bqag102-B24","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1046\/j.1432-1327.2000.01737.x","article-title":"Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors","volume":"267","author":"Smit","year":"2000","journal-title":"Eur J Biochem"},{"issue":"9","key":"2026091005362459500_bqag102-B25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00018-018-2748-5","article-title":"Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming","volume":"75","author":"Malik","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2026091005362459500_bqag102-B26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1097-2765(01)00336-7","article-title":"Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping","volume":"8","author":"Rem\u00e9nyi","year":"2001","journal-title":"Mol Cell"},{"issue":"2","key":"2026091005362459500_bqag102-B27","doi-asserted-by":"crossref","first-page":"e1003288","DOI":"10.1371\/journal.pgen.1003288","article-title":"SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state","volume":"9","author":"Lodato","year":"2013","journal-title":"PLoS Genet"},{"issue":"3","key":"2026091005362459500_bqag102-B28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1755-148X.2010.00697.x","article-title":"Genome-wide analysis of POU3F2\/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene","volume":"23","author":"Kobi","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"2026091005362459500_bqag102-B29","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/s41467-026-69308-0","article-title":"Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity","volume":"17","author":"Singh","year":"2026","journal-title":"Nat Commun"},{"issue":"3","key":"2026091005362459500_bqag102-B30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/nar\/gkz1144","article-title":"Phosphorylation of Tet3 by cdk5 is critical for robust activation of BRN2 during neuronal differentiation","volume":"48","author":"Rao","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2026091005362459500_bqag102-B31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/MCB.06257-11","article-title":"Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation","volume":"32","author":"Berlin","year":"2012","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2026091005362459500_bqag102-B32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajhg.2023.04.010","article-title":"Monoallelic intragenic POU3F2 variants lead to neurodevelopmental delay and hyperphagic obesity, confirming the gene's candidacy in 6q16. 1 deletions","volume":"110","author":"Sch\u00f6nauer","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2026091005362459500_bqag102-B33","doi-asserted-by":"crossref","first-page":"101389","DOI":"10.1016\/j.jbc.2021.101389","article-title":"An acetylation-enhanced interaction between transcription factor Sox2 and the steroid receptor coactivators facilitates Sox2 transcriptional activity and function","volume":"297","author":"Huang","year":"2021","journal-title":"J Biol Chem"},{"key":"2026091005362459500_bqag102-B34","doi-asserted-by":"crossref","first-page":"843794","DOI":"10.3389\/fnins.2022.843794","article-title":"Genetic regulation of vertebrate forebrain development by homeobox genes","volume":"16","author":"Leung","year":"2022","journal-title":"Front Neurosci"},{"issue":"5559","key":"2026091005362459500_bqag102-B35","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.1067132","article-title":"Transcriptional regulation of cortical neuron migration by POU domain factors","volume":"295","author":"McEvilly","year":"2002","journal-title":"Science"},{"issue":"14","key":"2026091005362459500_bqag102-B36","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gad.978002","article-title":"Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons","volume":"16","author":"Sugitani","year":"2002","journal-title":"Genes Dev"},{"issue":"1","key":"2026091005362459500_bqag102-B37","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1038\/s41467-024-52443-x","article-title":"Conserved transcriptional regulation by BRN1 and BRN2 in neocortical progenitors drives mammalian neural specification and neocortical expansion","volume":"15","author":"Bar\u00e3o","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"2026091005362459500_bqag102-B38","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1038\/s41380-020-00877-2","article-title":"Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular functions implicated in schizophrenia","volume":"26","author":"Ding","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"12","key":"2026091005362459500_bqag102-B39","first-page":"4325","article-title":"POU3F2 regulates canonical Wnt signalling via SOX13 and ADNP to expand the neural progenitor population","volume":"148","author":"Benoit","year":"2025","journal-title":"Brain"},{"issue":"10","key":"2026091005362459500_bqag102-B40","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mp.2015.207","article-title":"Prenatal \u03b2-catenin\/Brn2\/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors","volume":"21","author":"Belinson","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2026091005362459500_bqag102-B41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1101\/gad.301887.117","article-title":"Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors","volume":"32","author":"Chai","year":"2018","journal-title":"Genes Dev"},{"issue":"9","key":"2026091005362459500_bqag102-B42","doi-asserted-by":"crossref","first-page":"eabl7263","DOI":"10.1126\/sciadv.abl7263","article-title":"BRN2 as a key gene drives the early primate telencephalon development","volume":"8","author":"Zhu","year":"2022","journal-title":"Sci Adv"},{"issue":"24","key":"2026091005362459500_bqag102-B43","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1101\/gad.9.24.3109","article-title":"The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse","volume":"9","author":"Nakai","year":"1995","journal-title":"Genes Dev"},{"issue":"24","key":"2026091005362459500_bqag102-B44","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1101\/gad.9.24.3122","article-title":"Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2","volume":"9","author":"Schonemann","year":"1995","journal-title":"Genes Dev"},{"issue":"5","key":"2026091005362459500_bqag102-B45","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/gbe\/evu072","article-title":"Mammalian-specific sequences in pou3f2 contribute to maternal behavior","volume":"6","author":"Nasu","year":"2014","journal-title":"Genome Biol Evol"},{"key":"2026091005362459500_bqag102-B46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fgeed.2020.00007","article-title":"The iNs and outs of direct reprogramming to induced neurons","volume":"2","author":"Carter","year":"2020","journal-title":"Front Genome Ed"},{"issue":"7284","key":"2026091005362459500_bqag102-B47","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"issue":"4","key":"2026091005362459500_bqag102-B48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.celrep.2018.09.067","article-title":"KMT2B is selectively required for neuronal transdifferentiation, and its loss exposes dystonia candidate genes","volume":"25","author":"Barbagiovanni","year":"2018","journal-title":"Cell Rep"},{"issue":"4","key":"2026091005362459500_bqag102-B49","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41374-019-0343-5","article-title":"SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer","volume":"100","author":"Li","year":"2020","journal-title":"Lab Invest"},{"issue":"9","key":"2026091005362459500_bqag102-B50","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41556-021-00743-5","article-title":"An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer","volume":"23","author":"Davies","year":"2021","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2026091005362459500_bqag102-B51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41467-019-14219-6","article-title":"MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer","volume":"11","author":"Yasumizu","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2026091005362459500_bqag102-B52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","article-title":"Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation","volume":"37","author":"Zhang","year":"2020","journal-title":"Cancer cell"},{"issue":"23","key":"2026091005362459500_bqag102-B53","doi-asserted-by":"crossref","first-page":"e185952","DOI":"10.1172\/jci.insight.185952","article-title":"ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer","volume":"9","author":"Nouruzi","year":"2024","journal-title":"JCI Insight"},{"issue":"21","key":"2026091005362459500_bqag102-B54","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","article-title":"Neuroendocrine differentiation in prostate cancer requires ASCL1","volume":"84","author":"Rodarte","year":"2024","journal-title":"Cancer Res"},{"issue":"6","key":"2026091005362459500_bqag102-B55","first-page":"397","article-title":"Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer","volume":"10","author":"Qian","year":"2022","journal-title":"Am J Clin Exp Urol"},{"issue":"13","key":"2026091005362459500_bqag102-B56","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2026091005362459500_bqag102-B57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41420-024-02031-1","article-title":"Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1\/EZH2-mediated downregulation of REST","volume":"10","author":"Zheng","year":"2024","journal-title":"Cell Death Discov"},{"issue":"8","key":"2026091005362459500_bqag102-B58","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41588-025-02265-4","article-title":"NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling","volume":"57","author":"Lu","year":"2025","journal-title":"Nat Genet"},{"issue":"11","key":"2026091005362459500_bqag102-B59","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","article-title":"The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1","volume":"5","author":"Romero","year":"2024","journal-title":"Nat Cancer"},{"issue":"10","key":"2026091005362459500_bqag102-B60","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J Clin Invest"},{"issue":"7","key":"2026091005362459500_bqag102-B61","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pros.24497","article-title":"Clinical, pathologic, and molecular features of amphicrine prostate cancer","volume":"83","author":"Graham","year":"2023","journal-title":"Prostate"},{"issue":"1","key":"2026091005362459500_bqag102-B62","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun Biol"},{"issue":"4","key":"2026091005362459500_bqag102-B63","doi-asserted-by":"crossref","first-page":"111123","DOI":"10.1016\/j.celrep.2022.111123","article-title":"Dynamic plasticity of prostate cancer intermediate cells during androgen receptor-targeted therapy","volume":"40","author":"Sandhu","year":"2022","journal-title":"Cell Rep"},{"issue":"21","key":"2026091005362459500_bqag102-B64","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1158\/1078-0432.CCR-19-0498","article-title":"BRN4 is a novel driver of neuroendocrine differentiation in castration-resistant prostate cancer and is selectively released in extracellular vesicles with BRN2","volume":"25","author":"Bhagirath","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2026091005362459500_bqag102-B65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/cancers16040805","article-title":"Tissue-based diagnostic biomarkers of aggressive variant prostate cancer: a narrative review","volume":"16","author":"Kouroukli","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2026091005362459500_bqag102-B66","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI127961","article-title":"N-Myc\u2013mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer","volume":"129","author":"Berger","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"2026091005362459500_bqag102-B67","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-023-06876-5","article-title":"Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation","volume":"198","author":"Zhang","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2026091005362459500_bqag102-B68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41389-020-00247-1","article-title":"BRN2 expression increases anoikis resistance in melanoma","volume":"9","author":"Pierce","year":"2020","journal-title":"Oncogenesis"},{"issue":"2","key":"2026091005362459500_bqag102-B69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11912-020-01003-9","article-title":"Clinical and biological features of neuroendocrine prostate cancer","volume":"23","author":"Yamada","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2026091005362459500_bqag102-B70","doi-asserted-by":"crossref","first-page":"110595","DOI":"10.1016\/j.celrep.2022.110595","article-title":"Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis","volume":"39","author":"Han","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"2026091005362459500_bqag102-B71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00280-025-04790-9","article-title":"Peptides derived from the POU domain of BRN2 show antitumor activity against murine melanoma model cells in vitro and in vivo","volume":"95","author":"Cesar","year":"2025","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2026091005362459500_bqag102-B72","doi-asserted-by":"crossref","first-page":"71","DOI":"10.21873\/anticanres.16789","article-title":"Peptide L13S derived from the BRN2 POU domain reduces metastasis in vivo and inhibits cell migration and invasion in vitro","volume":"44","author":"Cesar","year":"2024","journal-title":"Anticancer Res"},{"issue":"12","key":"2026091005362459500_bqag102-B73","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.62347\/NBNQ6383","article-title":"Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines","volume":"16","author":"Purcell","year":"2024","journal-title":"Am J Transl Res"},{"issue":"1","key":"2026091005362459500_bqag102-B74","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat Commun"},{"issue":"15","key":"2026091005362459500_bqag102-B75","doi-asserted-by":"crossref","first-page":"e167440","DOI":"10.1172\/jci.insight.167440","article-title":"LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function","volume":"8","author":"Kumaraswamy","year":"2023","journal-title":"JCI Insight"},{"issue":"6","key":"2026091005362459500_bqag102-B76","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41388-021-02135-3","article-title":"RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition","volume":"41","author":"Han","year":"2022","journal-title":"Oncogene"},{"issue":"17","key":"2026091005362459500_bqag102-B77","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/1078-0432.CCR-20-4968","article-title":"BET bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2026091005362459500_bqag102-B78","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-22-2433","article-title":"LSD1 inhibition disrupts super-enhancer\u2013driven oncogenic transcriptional programs in castration-resistant prostate cancer","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res"},{"issue":"21","key":"2026091005362459500_bqag102-B79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161858","article-title":"A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer","volume":"132","author":"Zhao","year":"2022","journal-title":"J Clin Invest"},{"issue":"1","key":"2026091005362459500_bqag102-B80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s43856-022-00182-9","article-title":"Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes","volume":"2","author":"Ning","year":"2022","journal-title":"Commun Med (Lond)"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag102\/70929379\/bqag102.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/10\/bqag102\/70929379\/bqag102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/10\/bqag102\/70929379\/bqag102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:36:34Z","timestamp":1789032994000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag102\/8780684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag102","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,3]]},"article-number":"bqag102"}}